Relationships between cycling hypoxia, HIF-1, angiogenesis and oxidative stress
- PMID: 19929412
- PMCID: PMC2790140
- DOI: 10.1667/RR1926.1
Relationships between cycling hypoxia, HIF-1, angiogenesis and oxidative stress
Abstract
This Failla Lecture focused on the inter-relationships between tumor angiogenesis, HIF-1 expression and radiotherapy responses. A common thread that bonds all of these factors together is microenvironmental stress caused by reactive oxygen and nitrogen species formed during tumor growth and angiogenesis or in response to cytotoxic treatment. In this review we focus on one aspect of the crossroad between oxidative stress and angiogenesis, namely cycling hypoxia. Understanding of the relative importance of this feature of the tumor microenvironment has recently expanded; it influences tumor biology in ways that are separate from chronic hypoxia. Cycling hypoxia can influence angiogenesis, treatment responses and metastatic behavior. It represents an important and relatively less well understood feature of tumor biology that requires additional research.
Figures






Similar articles
-
The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.Bull Cancer. 2006 Aug;93(8):E73-80. Bull Cancer. 2006. PMID: 16935775 Review.
-
Silver nanoparticles inhibit the function of hypoxia-inducible factor-1 and target genes: insight into the cytotoxicity and antiangiogenesis.Int J Nanomedicine. 2016 Dec 8;11:6679-6692. doi: 10.2147/IJN.S109695. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27994464 Free PMC article.
-
[Regulation of the Hypoxia-Inducible Factor-1alpha (HIF-1alpha): a breath of fresh air in hypoxia research].J Soc Biol. 2004;198(2):113-20. J Soc Biol. 2004. PMID: 15368959 Review. French.
-
HIF-1 and tumor progression: pathophysiology and therapeutics.Trends Mol Med. 2002;8(4 Suppl):S62-7. doi: 10.1016/s1471-4914(02)02317-1. Trends Mol Med. 2002. PMID: 11927290 Review.
-
The role of hypoxia-inducible factor-2 alpha in angiogenesis.J Cell Physiol. 2018 Dec;233(12):9087-9098. doi: 10.1002/jcp.26805. Epub 2018 Jul 3. J Cell Physiol. 2018. PMID: 29968905 Review.
Cited by
-
Inhibition of endothelial cell proliferation and tumor angiogenesis by up-regulating NDRG2 expression in breast cancer cells.PLoS One. 2012;7(2):e32368. doi: 10.1371/journal.pone.0032368. Epub 2012 Feb 29. PLoS One. 2012. Retraction in: PLoS One. 2020 Oct 8;15(10):e0240574. doi: 10.1371/journal.pone.0240574. PMID: 22393400 Free PMC article. Retracted.
-
The investigation of tumoral angiogenesis with HIF-1 alpha and microvessel density in women with endometrium cancer.J Turk Ger Gynecol Assoc. 2012 Mar 1;13(1):37-44. doi: 10.5152/jtgga.2012.02. eCollection 2012. J Turk Ger Gynecol Assoc. 2012. PMID: 24627673 Free PMC article.
-
Nrf2 Modulation in Breast Cancer.Biomedicines. 2022 Oct 21;10(10):2668. doi: 10.3390/biomedicines10102668. Biomedicines. 2022. PMID: 36289931 Free PMC article. Review.
-
Acute versus chronic hypoxia in tumors: Controversial data concerning time frames and biological consequences.Strahlenther Onkol. 2012 Jul;188(7):616-27. doi: 10.1007/s00066-012-0085-4. Epub 2012 Mar 29. Strahlenther Onkol. 2012. PMID: 22454045 Review.
-
m6A Modification Mediates Endothelial Cell Responses to Oxidative Stress in Vascular Aging Induced by Low Fluid Shear Stress.Oxid Med Cell Longev. 2023 Jan 27;2023:8134027. doi: 10.1155/2023/8134027. eCollection 2023. Oxid Med Cell Longev. 2023. PMID: 36743697 Free PMC article.
References
-
- Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671–674. - PubMed
-
- Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 1997;18:4–25. - PubMed
-
- Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13:9–22. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources